Related Experiment Video
Updated: Jun 3, 2026
07:35
Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
Published on: October 11, 2018
Determining the cutpoint of a continuous predictive biomarker via Bayesian sensitive subpopulation finding
1Department of Biomedical Statistics and Bioinformatics, Kyoto University Graduate School of Medicine, Kyoto, Japan.
Journal of Biopharmaceutical Statistics
|June 2, 2026
Summary
This study introduces a new Bayesian method to find optimal cutpoints for continuous biomarkers in clinical trials. This helps identify patient subgroups likely to benefit from specific treatments, improving decision-making.
Area of Science:
- Biostatistics
- Clinical Trials
- Translational Medicine
Background:
- Treatment effect heterogeneity is common in clinical practice.
- Continuous biomarkers are frequently measured but challenging to use for treatment decisions.
- Identifying sensitive subpopulations can explain treatment variations.
Purpose of the Study:
- To develop a statistically and clinically sound method for selecting biomarker cutpoints.
- To identify patient subpopulations that are sensitive to specific treatments.
- To guide treatment decisions using continuous biomarkers in clinical trials.
Main Methods:
- Utilized a Bayesian posterior probability approach for analyzing time-to-event outcomes and biomarkers.
- Developed a method to control the false-positive rate for statistical suitability.
- Incorporated a minimum clinically important difference for clinical relevance.
Main Results:
- Simulation studies demonstrated the method's effectiveness across various clinical scenarios.
- The proposed method successfully identified a statistically suitable decision rule.
- The approach provided a clinically reasonable interpretation by considering important differences.
Conclusions:
- The developed Bayesian method offers a robust approach to determining optimal continuous biomarker cutpoints.
- This method aids in identifying sensitive subpopulations for targeted therapies.
- It enhances clinical decision-making by integrating statistical rigor and clinical significance.
Keywords:
Bayesian posterior probabilityPredictive biomarkerrandomized clinical trialtime-to-event outcomeMore Related Videos
Related Concept Videos
01:24Kaplan-Meier Approach
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
01:19Survival Tree
Survival trees are a non-parametric method used in survival analysis to model the relationship between a set of covariates and the time until an event of interest occurs, often referred to as the "time-to-event" or "survival time." This method is particularly useful when dealing with censored data, where the event has not occurred for some individuals by the end of the study period, or when the exact time of the event is unknown.
Building a Survival Tree
Constructing a survival tree begins...
Building a Survival Tree
Constructing a survival tree begins...
01:09Censoring Survival Data
Survival analysis is a statistical method used to analyze time-to-event data, often employed in fields such as medicine, engineering, and social sciences. One of the key challenges in survival analysis is dealing with incomplete data, a phenomenon known as "censoring." Censoring occurs when the event of interest (such as death, relapse, or system failure) has not occurred for some individuals by the end of the study period or is otherwise unobservable, and it might have many different reasons...
01:12Analysis of Population Pharmacokinetic Data
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
01:15Receiver Operating Characteristic Plot
A ROC (Receiver Operating Characteristic) plot is a graphical tool used to assess the performance of a binary classification model by illustrating the trade-off between sensitivity (true positive rate) and specificity (false positive rate). By plotting sensitivity against 1 - specificity across various threshold settings, the ROC curve shows how well the model distinguishes between classes, with a curve closer to the top-left corner indicating a more accurate model. The area under the ROC curve...
01:02Quantifying and Rejecting Outliers: The Grubbs Test
Sometimes, a data set can have a recorded numerical observation that greatly deviates from the rest of the data. Assuming that the data is normally distributed, a statistical method called the Grubbs test can be used to determine whether the observation is truly an outlier. To perform a two-tailed Grubbs test, first, calculate the absolute difference between the outlier and the mean. Then, calculate the ratio between this difference and the standard deviation of the sample. This number is...